Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Calliditas

Calliditas
1991 FOUNDED
PUBLIC STATUS
11-20 EMPLOYEES
CALTX STOCK SYMBOL
1 INVESTMENTS
$8.93 SHARE PRICE (As of Friday Closing)
Description

Calliditas Therapeutics AB operates as a specialty pharmaceutical company in Sweden. The company is engaged in the provision of pharmaceutical products for patients with niche indications. It is focused on the development and commercialization of the product candidate Nefecon intended for the treatment of patients with the inflammatory renal disease IgA nephropathy, a disease that causes chronic inflammation of the kidneys.

Formerly Known As
Pharmalink
Ownership Status
Publicly Held
Financing Status
Formerly VC-backed
Primary Industry
Drug Discovery
Other Industries
Drug Delivery
Pharmaceuticals
Stock Exchange
STO
Primary Office
  • Wallingatan 26B
  • 111 24 Stockholm
  • Sweden

+46 08-411 00 00
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Calliditas’s full profile, request a free trial.

Calliditas Stock Performance

52 wk Range Market Cap Prev. Close EPS Average Volume Shares
$4.22 - $9.40 $346M $8.78 -$0.16 36.1K 38.7M

Calliditas Financials Summary

In Thousands,
USD
TTM
30-Sep-2019
FY 2018
31-Dec-2018
FY 2017
31-Dec-2017
FY 2016
31-Dec-2016
Enterprise Value 150,286 95,210
Revenue 14,840 0 0 0
EBITDA (5,827) (15,170) (9,887) (6,511)
Net Income (5,770) (15,176) (10,155) (6,642)
Total Assets 85,876 72,136 7,608 2,997
Total Debt 0 0 57 3,294
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Calliditas Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore Calliditas‘s full profile, request access.

Request full access to PitchBook

Calliditas Acquisitions (1)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
00000000 18-Mar-2015 000000000000000000 Drug Discovery
To view this company’s complete investment and acquisition history, request access »

Calliditas Investors

Investor Name Investor Type Holding Participating Rounds Investor Since Board Seat Contact Info

This information is reserved for PitchBook Platform users. To explore Calliditas‘s full profile, request access.

Request full access to PitchBook

Calliditas Executive Team (15)

Name Title Board
Seat
Contact
Info
Renee Julie Elisabeth Aguiar-Lucander Chief Executive Officer
Fredrik Johansson Chief Financial Officer
Marek Poszepczynski Director of Business Development
Anders Hultman Finance Director
Heather Cook Ph.D Regulatory Affairs Director

3 Former Executives

You’re viewing 5 of 15 executives. Get the full list »

Calliditas Board Members (9)

Name Representing Role Since Contact
Info
Ann-Tove Kongsnes Investinor Board Member 000 0000
Bengt Julander Self Co-Founder & Board Member 000 0000
Diane Parks Calliditas Board Member 000 0000
Elmar Schnee Self Chairman 000 0000
Hilde Furberg Self Board Member 000 0000

2 Former Board Members

You’re viewing 5 of 9 board members. Get the full list »